載入...

Cardiovascular Effects of Erythropoietin: An Update

Erythropoietin (EPO) is a therapeutic product of recombinant DNA technology and it has been in clinical use as stimulator of erythropoiesis over the last two decades. Identification of EPO and its receptor (EPOR) in the cardiovascular system expanded understanding of physiological and pathophysiolog...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Santhanam, Anantha Vijay R., d’Uscio, Livius V., Katusic, Zvonimir S.
格式: Artigo
語言:Inglês
出版: 2010
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3907121/
https://ncbi.nlm.nih.gov/pubmed/21081221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/B978-0-12-385061-4.00009-X
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!